1. Volume 2, Issue 1, Pages 7-9 (January 2016)
Exacerbation of bullous pemphigoid after hand, foot, and mouth disease treated with rituximab 
Alfreda F. Batts, BS, Sheila Z. Jalalat, MD, Lindsey Hunter-Ellul, MD, Michael G. Wilkerson, MD 
JAAD Case Reports 
Volume 2, Issue 1, Pages 7-9 (January 2016)
DOI: /j.jdcr
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Scattered erosions, crusts and tense bullae on the right superior anterolateral chest and axilla (A) and left upper arm and shoulder (B) 4 months after contracting HFMD.
JAAD Case Reports 2016 2, 7-9DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Postinflammatory hypopigmentation with patches of erythema and scattered milia on the left arm 6 months after initiating rituximab.
JAAD Case Reports 2016 2, 7-9DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

4. Fig 3
Patient's IgG BP antibody level (units) throughout course of treatment. Significant downward trending of his BP titers is noted. M, Months.
JAAD Case Reports 2016 2, 7-9DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions